PHASE II STUDY OF GEMCITABINE AND OXALIPLATIN IN UNRESECTABLE GALL BLADDER CANCER

被引：0
|
作者：
Uddin, M. [1 ]
Hannan, A. A. [1 ]
Ahmed, I. [1 ]
机构：
[1] Rajshahi Med Coll & Hosp, Dept Radiotherapy, Rajshahi, Bangladesh
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：248 / 248
页数：1
相关论文
共 50 条
  • [31] A phase II study of capecitabine and oxaliplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract
    Graham J.S.
    Boyd K.
    Coxon F.Y.
    Wall L.R.
    Eatock M.M.
    Maughan T.S.
    Highley M.
    Soulis E.
    Harden S.
    Bützberger-Zimmerli P.
    Evans T.R.J.
    BMC Research Notes, 9 (1)
  • [32] Transarterial infusion with gemcitabine and oxaliplatin for the treatment of unresectable pancreatic cancer
    Chen, Yi
    Wang, Xiao-Lin
    Wang, Jian-Hua
    Yan, Zhi-Ping
    Cheng, Jie-Min
    Gong, Gao-Quan
    Liu, Ling-Xiao
    Li, Guo-Ping
    Li, Chang-Yu
    ANTI-CANCER DRUGS, 2014, 25 (08) : 958 - 963
  • [33] Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study
    Demols, A
    Peeters, M
    Polus, M
    Marechal, R
    Gay, F
    Monsaert, E
    Hendlisz, A
    Van Laethem, JL
    BRITISH JOURNAL OF CANCER, 2006, 94 (04) : 481 - 485
  • [34] Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study
    A Demols
    M Peeters
    M Polus
    R Marechal
    F Gay
    E Monsaert
    A Hendlisz
    J L Van Laethem
    British Journal of Cancer, 2006, 94 : 481 - 485
  • [35] Modified gemcitabine and oxaliplatin or gemcitabine plus cisplatin in unresectable gallbladder cancer: Results of a phase III randomised controlled trial
    Sharma, Atul
    Mohanti, Bidhu Kalyan
    Chaudhary, Surendra Pal
    Sreenivas, V.
    Sahoo, Ranjit Kumar
    Shukla, Nootan Kumar
    Thulkar, Sanjay
    Pal, Sujoy
    Deo, Surya V.
    Pathy, Sushmita
    Dash, Nihar Ranjan
    Kumar, Sunil
    Bhatnagar, Sushma
    Kumar, Rakesh
    Mishra, Seema
    Sahni, Peush
    Iyer, Venkateswaran K.
    Raina, Vinod
    EUROPEAN JOURNAL OF CANCER, 2019, 123 : 162 - 170
  • [36] Palliative therapy in unresectable advanced gall bladder cancer A
    Khatri, P.
    Kumari, P.
    ANNALS OF ONCOLOGY, 2016, 27 : 91 - 92
  • [37] A phase II study of gemcitabine (G) and capecitabine (C) in advanced cholangiocarcinoma (CC) and gall bladder carcinoma (GBC).
    Iyer, RV
    Gibbs, J
    Lawrence, D
    Soehnlein, N
    Kuvshinoff, B
    Javle, MM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 365S - 365S
  • [38] Phase II study of salvage mFOLFOX (5-fluorouracil, leucovorin, oxaliplatin) in patients with unresectable biliary tract cancer who had failed gemcitabine
    Hwang, I.
    Jang, J. S.
    Oh, S. Y.
    Sun, J. M.
    Nam, E. M.
    Lee, H. R.
    Jun, H. J.
    Chi, K. C.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S630 - S630
  • [39] JASPAC 02: A phase II study of gemcitabine and oxaliplatin (GEMOX) for gemcitabine-refractory advanced biliary tract cancer
    Ohno, I.
    Fukutomi, A.
    Furuse, J.
    Okusaka, T.
    Asayama, M.
    Nakamori, S.
    Ishii, H.
    Okuno, T.
    Yamanaka, T.
    Boku, N.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S631 - S632
  • [40] A multicenter phase II study of gemcitabine (GEM) in patients with unresectable biliary tract cancer.
    Funakoshi, A
    Okusaka, T
    Ishii, H
    Yamao, K
    Ohkawa, S
    Saito, H
    Saito, S
    Tsuyuguchi, T
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 344S - 344S
12345